QUICKLINKS AND VIEW OPITONS
Hydroxychloroquine decreased mortality in critically-ill COVID-19 patients (19% vs 46%)
Wednesday, May 06, 2020 4:07 pm Email this article
Among 568 critically-ill patients treated in a similar manner, 45.8% of those not given hydroxychloroquine died (238/520) versus 18.8% of those given hydroxychloroquine (9/48) — 200 mg twice a day for 7-10 days — according to a retrospective study from China.
The authors of the study concluded:
“Hydroxychloroquine treatment is significantly associated with a decreased mortality in critically ill patients with COVID-19…
Therefore, hydroxychloroquine should be prescribed for treatment of critically ill COVID-19 patients to save lives.”
Running Title: Hydroxychloroquine decreases COVID-19 mortality
Corresponding Author’s Contact Info
Dao Wen Wang, MD, PhD
Division of Cardiology, Department of Internal Medicine
Tongji Hospital, Tongji Medical College
Huazhong University of Science and Technology
1095 Jiefang Ave., Wuhan 430030, China
The study is posted here:
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.